Latigo Biotherapeutics, Inc.

Latigo Biotherapeutics is a clinical-stage biotechnology company focused on developing innovative, non-opioid pain medicines. Recognizing the significant unmet need for effective pain management solutions that do not carry the risk of addiction, Latigo aims to disrupt the current standard of care by targeting pain at its source. Their research and development efforts are based on unique in-house research and insights, leveraging their expertise in ion channels to develop best-in-class pain therapies.

Latigo's lead program, LTG-001, is a potential best-in-class non-opioid Nav1.8 inhibitor, demonstrating promising results in Phase 1 clinical trials. The company is actively advancing its robust pipeline of novel pain therapeutics, driven by a commitment to provide patients with safer, more effective pain relief options. Latigo is supported by leading investors, including Westlake Village BioPartners, 5AM Ventures, Foresite Capital, and Corner Ventures, reflecting the company's potential to become a global leader in non-opioid pain management.

Latigo Biotherapeutics, Inc. values the scientific rigor and collaboration needed to create a rewarding work environment for its employees. While the company website mentions "join our team," there is no specific information provided regarding job flexibility, such as remote work options, flexible hours, or hybrid schedules.

Latigo Biotherapeutics is a clinical-stage biotechnology company dedicated to developing innovative, non-opioid pain medications that target the source of pain, aiming to provide effective and rapid-acting pain relief without the risk of addiction. Their mission is to offer a new class of medicines to treat pain effectively, without the dependence and potential for addiction associated with current treatments, ultimately restoring health and quality of life for patients.

Latigo Biotherapeutics fosters a collaborative and forward-thinking culture that prioritizes scientific rigor, patient focus, and open dialogue. The company values the contributions of its employees and encourages them to push boundaries in their pursuit of developing innovative non-opioid pain medicines. This dedication to scientific excellence and patient well-being creates a rewarding work environment where employees feel valued and empowered to make a difference in the lives of those suffering from pain.

Latigo Biotherapeutics values scientific rigor, collaboration, and creating a rewarding work environment for its employees. They are committed to fostering a diverse and inclusive culture, where individuals from all backgrounds feel valued, respected, and empowered to contribute their unique perspectives and talents. Their website highlights their commitment to changing the lives of patients and creating a positive work environment for employees, but it lacks specific details on their approach to diversity, equity, and inclusion.